Medical cannabis oil is now being produced in Sweden
Sweden has become the first country in the world where medical cannabis oil is being produced by a government owned company.

Doctors at a pain clinic in Stockholm have been prescribing cannabis oil
to patients with a number of different indications, such as chronic
neuropathic pain, arthritis, and rheumatism. This has led to medical cannabis oils finally being produced in Sweden.
It is a government owned company with a laboratory for pharmaceutical
manufacturing that is now producing cannabis oil for medical use in
Sweden.
The preparations are what is called "extempore" or "magistral"
preparations in the pharmaceutical industry, and contain both CBD and
THC i liquid form for drip dosing. More than 500 Swedish patients have
received prescriptions for the cannabis oils from their doctors.
Medical cannabis has been available as a registered pharmaceutical in
Sweden since 2011 when Sativex, a mouth spray with cannabis oil, was
registered for the treatment of multiple sclerosis. Another cannabis
based drug, Epydiolex, was registered in October 2020 as a treatment for
certain kinds of epilepsy. Since 2017, pharmaceutical cannabis from the
Netherlands and Canada has also been available for patients under
license.
The number of medical cannabis patients in Sweden is increasing
steadily, from about 500 patients in 2018 to about 2000 patients in
2020. The prognosis for 2021 is that over 4000 patients will have
prescriptions for medical cannabis.
Questions about the pain clinic Aureum Healthcare in Stockholm, or its
owner the cannabis investment company Aureum Life can be answered by the
press spokesperson for the companies, Christian Engström.
More information about the cannabis oils, the process that made them
available to pain patients in Sweden, and why this matters can be found
in an independent article that will be published at Cannabis i Fokus [1]
shortly. Cannabis i Fokus is Swedens fastest growing news site focused
on news regarding cannabis.
Keywords
Contacts
Otto LarssonCannabis i fokus / Chefsredaktör
otto.larsson@cannabisifokus.seImages
About Cannabis i fokus
Cannabis in focus is a Swedish news magazine about cannabis and was launched on April 20, 2021. The magazine is politically independent and does not take a stand for a party or on individual issues. The editorial staff works instead to make the magazine a platform that gathers all the news, knowledge and conversations about cannabis.
All articles published in the journal must be based on facts, empirical research and recognized methods. We lean on journalistic principles and are careful with our sources.
Subscribe to releases from Cannabis i fokus
Subscribe to all the latest releases from Cannabis i fokus by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Cannabis i fokus
Sweden's first Cannabis conference "SMCC 2022" Stockholm Medical Cannabis Conference21.3.2022 13:06:32 CET | Press release
A Swedish cannabis company believes the time is right for Swedish healthcare to start taking medical cannabis seriously. Medical cannabis has come to Sweden to stay. Sweden today has more the 4000 patients who get prescriptions for medical cannabis against symptoms like chronic pain and tremors.
Nu tillverkas Cannabisolja i Sverige!1.9.2021 09:50:37 CEST | Pressmeddelande
Sverige är nu första land i världen med statligt ägd tillverkning av medicinsk cannabisolja!
Cannabisnyheter siktar mot Börsen30.7.2021 08:20:45 CEST | Pressmeddelande
Nyhetssajten Cannabis i Fokus siktar på att ta sig till börsen. Därför genomför man nu en spridningsemission med målet att bli en läsarägd nyhetspublicist med fokus på Cannabis.